Amgen “Off To Strong Start” Under ASP Reimbursement System
This article was originally published in The Pink Sheet Daily
Executive Summary
“As each day goes by, we feel better” about ASP-based reimbursement for Medicare Part B drugs, CEO Sharer says. CMS’ “quality of care” demonstration project helps Amgen’s first quarter performance, resulting in increased guidance for 2005. Company execs predict the demo program will continue into 2006 due to “strong lobbying.”